What happens after GLP-1s and why food will matter more than ever

A University of Oxford study published in The BMJ finds users of GLP-1 drugs like Ozempic regain weight and reverse heart health improvements within two years of stopping treatment.
China-founded pharma Corxel raises up to $287M for oral GLP-1

Since its 2019 founding, Corxel Pharmaceuticals has evolved from focusing on the China market to eyeing the world. The biopharma, founded in Shanghai but now headquartered in New Jersey, has raised as much as …
Off the Scales: ‘meticulously reported’ rise of Ozempic

In 2024, the US Centers for Disease Control and Prevention published “what could well be the most important table in modern public health”, said Tom Whipple in The Times. For decades, American waistlines had been expanding “inexorably”. But the 2024 assessment of “how fat the country was” revealed a change: the “number of fat people […]
China-rooted Corxel raises up to $287M for GLP-1 pill with global ambitions – Endpoints News

China-rooted Corxel raises up to $287M for GLP-1 pill with global ambitions Endpoints News
CoreAge Rx Introduces Flat-Rate Pricing for GLP-1 Medications

WICHITA FALLS, Texas, Jan. 22, 2026 /PRNewswire/ — CoreAge Rx, a telehealth pharmacy specializing in weight management solutions, today announced a pricing structure designed to eliminate hidden fees and provide predictable costs for patients seeking GLP-1 medications. The company now…
Simply Good Foods turns again to ex-CEO amid GLP-1 advance

The US group has re-hired former CEO Joe Scalzo as sales falter and as GLP-1 trend presents opening for Atkins brand.
6 New Weight Loss Drugs That Could Dethrone Ozempic – Gizmodo

6 New Weight Loss Drugs That Could Dethrone Ozempic Gizmodo What difference will a GLP-1 pill make? Wisconsin weight loss physician weighs in wpr.org Powerful New Weight-Loss Drugs May Outperform Ozempic With ‘Profound’ Results TODAY.com Doctor answers questions about GLP-1 medications ny1.com How To Stay Strong on a GLP-1 diaTribe
AI drug startup Insilico Medicine launches an AI ‘gym’ to help models like GPT and Qwen be good at science

Insilico Medicine, a U.S.-based, Hong Kong-listed AI drug discovery company, is launching a new service that will train general-purpose large language models, like OpenAI’s GPT or Alibaba’s Qwen, to handle biology and chemistry tasks. Generalist models “fail miserably” at the benchmarks used to measure how AI performs scientific tasks, Alex Zhavoronkov, Insilico’s founder and CEO, […]
After GLP-1: Weight regain, food fear and the industry’s next reckoning

As millions quit GLP-1 drugs and weight rebounds faster than expected, food makers face rising pressure around nutrition, trust and mental health.
4p hot drink that could mimic the effects of weight loss jabs

Research has found that natural compounds could affect GLP-1